BPC?157 is a synthetic stable pentadecapeptide derived from a naturally occurring gastric juice protein fragment, serving as a well-studied research peptide for tissue repair and regenerative related laboratory investigations. This peptide participates in multiple biological repair pathways, supporting angiogenesis, modulating inflammatory responses and promoting the migration and proliferation of fibroblasts, endothelial cells and other tissue cells. In preclinical animal studies, it is widely explored for research involving tendon, ligament, muscle, skin, gastrointestinal mucosal injury and joint damage recovery models.

It is synthesized by standard solid-phase peptide synthesis technology and refined through multi-step reversed-phase HPLC purification, effectively removing truncated peptide impurities, oxidation by-products and residual organic solvents. Each batch comes with full COA certification covering HPLC purity check, MS molecular weight confirmation, moisture test, residual solvent detection, endotoxin assay and microbial limit test to guarantee consistent quality between batches. The lyophilized powder formulation slows down peptide degradation and hydrolysis, offering good stability for cross-border logistics and long-term sample storage. Applicable research scenarios contain in vitro cell wound healing assays, inflammatory mechanism research, in vivo animal tissue injury model evaluation and peptide stability analysis.